Baczol Cold Medicine Syrup
NDC Package 76864-208-01
Package Information
Baczol Cold Medicine (acetaminophen, dextromethorphan hbr, chlorpheniramine maleate, phenylephrine hcl) syrups is uses • Temporarily relieves runny nose, sneezing, itching ofthe nose or throat, and itchy, watery eyes due to hay fever • nasalcongestion due to the common cold • Calms the cough controlcenter and relieves coughing • minor aches and pains associatedwith the common cold • temporarily reduces fever. This formulation utilizes a syrup delivery system. Marketed by Procaps S.a. De C.v., this product is identified by NDC 76864-208 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1370440 - acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution
- RxCUI: 1370440 - acetaminophen 50 MG/ML / chlorpheniramine maleate 0.8 MG/ML / dextromethorphan hydrobromide 2 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
- RxCUI: 1370440 - acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 10 per 5 ML Oral Solution
- RxCUI: 1370440 - APAP 50 MG/ML / Chlorpheniramine Maleate 0.8 MG/ML / Dextromethorphan Hydrobromide 2 MG/ML / Phenylephrine Hydrochloride 2 MG/ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 76864 - Procaps S.a. De C.v.
- 76864-208 - Baczol Cold Medicine
- 76864-208-01 - 1 BOTTLE, PLASTIC in 1 CARTON / 120 mL in 1 BOTTLE, PLASTIC
- 76864-208 - Baczol Cold Medicine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76864-208-01 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 120 ml in 1 bottle, plastic of Baczol Cold Medicine, a human over the counter drug labeled by Procaps S.a. De C.v.. This syrup is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Procaps S.a. De C.v. on May 25, 2020. The current certification is valid through December 31, 2026.
How is this Procaps S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76864020801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.